doi: 10.1038/nrn3961 202 CandeiasESebastioICardosoSCarvalhoCSantosMSOliveiraCRet al
Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined. The New England Journal of Medicine, vol
Heres what I typically see: Ozempic: Usually covered if you have diabetes, often with reasonable copays Wegovy: More variable coverage
For example, semaglutide 2.4 mg (Wegovy) yields approximately 15% body weight reduction in clinical trials, while lower doses used for diabetes (Ozempic) produce more modest weight loss
Conversely, individuals already achieving good glycemic control on tirzepatide monotherapy, those with recurrent hypoglycemic episodes, or those taking multiple insulin-sensitizing agents (e.g., pioglitazone + metformin + tirzepatide) should consult their provider before adding inositol
In every case, a clear dose history helps guide the conversation